Track the Oxford BioDynamics Plc stock price and the full insider trade history of the company, a listed equity based in United Kingdom. Shares trade on UK GB, under the supervision of RNS (LSE). The latest transaction was reported on 10 April 2025 (Purchase). Among the most active insiders: Stephen Diggle. Every trade is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€17,256
3 ops.
Buy Volume
€111,995
3 ops.
Sell Volume
22Σ signal
Buys €17,256€111,995 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
443,673 shares@ £0.1495100.0% of flowXLONRNS:4886895
7 of 7 declarations
About Oxford BioDynamics Plc
Oxford BioDynamics Plc is a biotechnology company focused on developing diagnostic tests based on epigenetic biomarkers. It concentrates on applications in healthcare, particularly for cancer and autoimmune diseases.